Infectious Disease Consequences of Opioid Use

View this ASTHOConnect webinar to learn about opportunities to assess, prepare, and implement programs that prevent the spread of HIV, viral hepatitis, and other infectious diseases related to the opioid epidemic. Expert panelists discuss evidence-based practices that reduce the harmful health outcomes associated with injection drug use and link clients to treatment programs. 

State and local representatives from Vermont share their perspectives on policy levers and activities needed at the community level to implement syringe services programs (SSPs). Representatives also share lessons learned related to developing and implementing SSPs and building linkages to treatment for substance misuse.

Alice K. Asher

Epidemiologist, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC

Daniel J. Daltry

Program Chief, HIV/ STD/ Hepatitis Program, Vermont Department of Health

Grace Keller

Program Coordinator, Howard Center Safe Recovery

Key:

Complete
Failed
Available
Locked
Infectious Disease Consequences of Opioid Use
Open to view video.
Open to view video. ASTHO and CDC hosted an ASTHOConnects on evidence-based practices that prevent infectious diseases related to the opioid epidemic. CDC, Vermont state and local representatives shared their perspectives on policy levers and partnerships for implementing syringe services programs (SSPs) and building linkages to treatment for substance misuse.